Skip to main content
SpringerLink
Log in

Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

In the present study, we analyzed (1) the type of HPV infection and (2) the frequency of loss of heterozygosity and microsatellite imbalance (LOH/MSI) in normal cytology and cervical intraepithelial neoplasia (CIN1-3). The cytological material included: low-grade squamous intraepithelial lesions (CIN1, n = 11), high-grade lesions (CIN2 and CIN3, n = 13), and cytologically normal cells from non-neoplastic cervical samples (n = 8). HPV genotyping was done using RealLine HPV 16/18 kit. We used 20 microsatellite markers from: 1p31.2, 3p14.3, 3p21.3, 3p22.2, 3p24.2, 3p25.3, 7q32.2, 9p21.3, 11p15.5, 12q23.2, and 16q22.1. LOH/MSI was correlated with clinicopathological parameters. The presence of HPV DNA was revealed in 78.13 % samples, including normal cytology. LOH/MSI was the most frequent for: 3p25.3 (39 %), 3p22.2 (20.83 %), 3p24.2 (20 %), and 3p14.3 (16.67 %). It was demonstrated that D3S1234 (FHIT; 3p14.3), D3S1611 (MLH1; 3p22.2), D3S1583 (RARB; 3p24.2), D3S1317 and D3S3611 (VHL; 3p25.3) could differentiate patients with CIN2/CIN3 versus CIN1, showing significantly higher frequency in CIN2/CIN3. LOH/MSI frequency for other than 3p markers was lower, 10–22.2 %. The simultaneous occurrence of LOH/MSI for several markers (OFAL) was higher in CIN2/CIN3. Significant differences in OFAL were found between samples with versus without HPV infection. In HPV-positive patients, significant differences in OFAL were found between normal cytology, CIN1 and CIN2/CIN3. HPV infection influences the increase in LOH/MSI frequency, especially in tumor suppressor gene loci. Several studied microsatellite markers seem to be useful for CIN grading. Hopefully, the obtained results, if confirmed on larger patient cohort, would allow creating a panel of markers supporting clinical diagnosis in patients with HPV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Castellsagué X, Bruni L, Brotons M, Barrionuevo L, Serrano B, Muñoz J, Bosch FX, de Sanjosé S. ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Poland. PREHDICT edition. Summary report 2015. http://www.hpvcentre.net/statistics/reports/POL.pdf.

  2. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.

    Article  PubMed  Google Scholar 

  3. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55:244–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24:26–34.

    Article  Google Scholar 

  5. Pastuszak-Lewandoska D, Bartosińska-Dyc A, Migdalska-Sęk M, Czarnecka KH, Nawrot E, Domańska D, Szyłło K, Brzeziańska E. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study. Med Oncol. 2014;31:842.

    Article  PubMed  Google Scholar 

  6. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Treviño V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabiño NB, Gómez-Macías GS, Valdez-Chapa LD, Garza-Rodríguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldaña HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M. Landscape of genomic alterations in cervical carcinomas. Nature. 2014;506:371–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS. Kucherlapati R; Cancer Genome Atlas Network. Characterization of HPV and host genome interactions in primary head and neck cancers. Proc Natl Acad Sci USA. 2014;111:15544–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. zur Hausen H. Papilloma viruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–8.

    Article  CAS  PubMed  Google Scholar 

  9. Syrjänen KJ. Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. Review article. APMIS. 1989;97:957–70.

    Article  PubMed  Google Scholar 

  10. Buckley CH, Butler EB, Fox H. Cervical intraepithelial neoplasia. J Clin Pathol. 1982;35:1–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bryś M, Migdalska-Sęk M, Pastuszak-Lewandoska D, Forma E, Czarnecka K, Domańska D, Nawrot E, Wilkosz J, Różański W, Brzeziańska E. Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers. Med Oncol. 2013;30:391.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Antczak A, Migdalska-Sęk M, Pastuszak-Lewandoska D, Czarnecka K, Nawrot E, Domańska D, Kordiak J, Górski P, Brzeziańska E. Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis. Med Oncol. 2013;30:532.

    Article  PubMed  PubMed Central  Google Scholar 

  13. van den Tillaart SA, Corver WE, Ruano Neto D, ter Haar NT, Goeman JJ, Trimbos JB, Fleuren GJ, Oosting J. Loss of heterozygosity and copy number alterations in flow-sorted bulky cervical cancer. PLoS One. 2013;8:e67414.

    Article  PubMed  PubMed Central  Google Scholar 

  14. ELhamidi A, Hamoudi RA, Kocjan G, Du MQ. Cervical intraepithelial neoplasia: prognosis by combined LOH analysis of multiple loci. Gynecol Oncol. 2004;94:671–9.

    Article  PubMed  Google Scholar 

  15. Acevedo CM, Henríquez M, Emmert-Buck MR, Chuaqui RF. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ. Cancer. 2002;94:793–802.

    Article  PubMed  Google Scholar 

  16. Chang CL, Wang SY, Wu CC, Su TH, Wang KL, Chen HS, Yang YC. Microsatellite alterations in exfoliated cervical epithelia deoxyribonucleic acid as a marker for high-grade dysplasia. Am J Obstet Gynecol. 2001;185:108–15.

    Article  CAS  PubMed  Google Scholar 

  17. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer. 1999;80:2008–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mirunalini S, Dhamodharan G, Karthishwaran K. Role of chromosome 3p22.3 in the development of cervical cancer. J Biochem Technol. 2012;3:328–30.

    CAS  Google Scholar 

  19. Zhao FX, Yan J, Liu RH, Wang XY, Cui K. Relationship between microsatellite alterations of RASSF1A gene and development of cervical carcinoma. Chin J Cancer Res. 2007;19:45–51.

    Article  CAS  Google Scholar 

  20. Butler D, Collins C, Mabruk M, Barry Walsh C, Leader MB, Kay EW. Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features. J Pathol. 2000;192:502–10.

    Article  CAS  PubMed  Google Scholar 

  21. Chung TK, Cheung TH, Lo WK, Yu MY, Hampton GM, Wong HK, Wong YF. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia. Cancer Lett. 2000;154:189–94.

    Article  CAS  PubMed  Google Scholar 

  22. Chatterjee A, Pulido HA, Koul S, Beleño N, Perilla A, Posso H, Manusukhani M, Murty VV. Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions. Cancer Res. 2001;61:2119–23.

    CAS  PubMed  Google Scholar 

  23. Guo Z, Hu X, Afink G, Pontén F, Wilander E, Pontén J. Comparison of chromosome 3p deletions between cervical precancers synchronous with and without invasive cancer. Int J Cancer. 2000;86:518–23.

    Article  CAS  PubMed  Google Scholar 

  24. Kersemaekers AM, Hermans J, Fleuren GJ, van de Vijver MJ. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer. 1998;77:192–200.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, Braga EA, Zabarovsky ER. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene. 2004;23:5719–28.

    Article  CAS  PubMed  Google Scholar 

  26. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002;21:6915–35.

    Article  CAS  PubMed  Google Scholar 

  27. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet. 2000;25:315–9.

    Article  CAS  PubMed  Google Scholar 

  28. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer. 2006;119:1908–14.

    Article  CAS  PubMed  Google Scholar 

  29. Ciavattini A, Piccioni M, Tranquilli AL, Filosa A, Pieramici T, Goteri G. Immunohistochemical expression of DNA mismatch repair (MMR) system proteins (hMLH1, hMSH2) in cervical preinvasive and invasive lesions. Pathol Res Pract. 2005;201:21–5.

    Article  CAS  PubMed  Google Scholar 

  30. Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res. 2003;9:2981–4.

    CAS  PubMed  Google Scholar 

  31. Senchenko V, Liu J, Braga E, Mazurenko N, Loginov W, Seryogin Y, Bazov I, Protopopov A, Kisseljov FL, Kashuba V, Lerman MI, Klein G, Zabarovsky ER. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene. 2003;22:2984–92.

    Article  CAS  PubMed  Google Scholar 

  32. Herzog CR, Crist KA, Sabourin CL, Kelloff GJ, Boone CW, Stoner GD, You M. Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas. Mol Carcinog. 2001;30:159–68.

    Article  CAS  PubMed  Google Scholar 

  33. Yoshino K, Enomoto T, Nakamura T, Sun H, Ozaki K, Nakashima R, Wada H, Saitoh J, Watanabe Y, Noda K, Murata Y. FHIT alterations in cancerous and non-cancerous cervical epithelium. Int J Cancer. 2000;85:6–13.

    Article  CAS  PubMed  Google Scholar 

  34. Kersemaekers AM, van de Vijver MJ, Kenter GG, Fleuren GJ. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Genes Chromosom Cancer. 1999;26:346–54.

    Article  CAS  PubMed  Google Scholar 

  35. Nishimura M, Furumoto H, Kato T, Kamada M, Aono T. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer. Gynecol Oncol. 2000;79:201–6.

    Article  CAS  PubMed  Google Scholar 

  36. Choi CH, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett. 2007;255:26–33.

    Article  CAS  PubMed  Google Scholar 

  37. Kozlowski L, Filipowski T, Rucinska M, Pepinski W, Janica J, Skawronska M, Poznanski J, Wojtukiewicz MZ. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy. Neoplasma. 2006;53:440–3.

    CAS  PubMed  Google Scholar 

  38. Luft F, Gebert J, Schneider A, Melsheimer P, von Knebel Doeberitz M. Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia. Int J Gynecol Pathol. 1999;18:374–80.

    Article  CAS  PubMed  Google Scholar 

  39. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072–9.

    Article  PubMed  Google Scholar 

  40. Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD, Gazdar AF. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res. 1997;57:3154–8.

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Molecular Bases of Medicine, 1st Chair of Internal Diseases, Medical University of Lodz, Pomorska St. No. 251, 92-213, Lodz, Poland

      Monika Migdalska-Sęk, Dorota Pastuszak-Lewandoska, Karolina H. Czarnecka, Ewa Nawrot, Daria Domańska-Senderowska, Justyna Kiszałkiewicz & Ewa Brzeziańska-Lasota

    2. Department of Pregnancy Pathology, 1st Chair of Gynecology and Obstetrics, Medical University of Lodz, Wileńska 37, 94-029, Lodz, Poland

      Agata Karowicz-Bilińska

    Authors
    1. Monika Migdalska-Sęk
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Agata Karowicz-Bilińska
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Dorota Pastuszak-Lewandoska
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Karolina H. Czarnecka
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Ewa Nawrot
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Daria Domańska-Senderowska
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Justyna Kiszałkiewicz
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Ewa Brzeziańska-Lasota
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Monika Migdalska-Sęk.

    Ethics declarations

    Conflict of interest

    None.

    Additional information

    Monika Migdalska-Sęk and Agata Karowicz-Bilińska have equally contributed to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Migdalska-Sęk, M., Karowicz-Bilińska, A., Pastuszak-Lewandoska, D. et al. Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study. Med Oncol 33, 51 (2016). https://doi.org/10.1007/s12032-016-0763-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1007/s12032-016-0763-7

    Keywords

    Search

    Navigation